NCT01520077View on ClinicalTrials.gov

Vytorin in the Treatment of Alopecia Areata

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Alopecia Areata
Interventions
DRUG

vytorin

Patient will take once per day by mouth Vytorin 10/40mg. Will take it for 24 weeks and then continue or discontinue treatment at that time and be monitored for 24 more weeks. Should there be no improvement by the initial 24 weeks then they will no longer be in the study.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT01520077 - Vytorin in the Treatment of Alopecia Areata | Biotech Hunter | Biotech Hunter